SK286603B6 - N-(4,5-bis-Metánsulfonyl-2- metylbenzoyl)guanidínhydrochloridhydrát a spôsob jeho prípravy - Google Patents

N-(4,5-bis-Metánsulfonyl-2- metylbenzoyl)guanidínhydrochloridhydrát a spôsob jeho prípravy Download PDF

Info

Publication number
SK286603B6
SK286603B6 SK546-2002A SK5462002A SK286603B6 SK 286603 B6 SK286603 B6 SK 286603B6 SK 5462002 A SK5462002 A SK 5462002A SK 286603 B6 SK286603 B6 SK 286603B6
Authority
SK
Slovakia
Prior art keywords
methanesulfonyl
bis
methylbenzoyl
guanidine
reaction
Prior art date
Application number
SK546-2002A
Other languages
English (en)
Slovak (sk)
Other versions
SK5462002A3 (en
Inventor
Rolf Gericke
Manfred Baumgarth
Hans Markus Bender
Bernhard Ladstetter
Original Assignee
Merck Patent Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck Patent Gmbh filed Critical Merck Patent Gmbh
Publication of SK5462002A3 publication Critical patent/SK5462002A3/sk
Publication of SK286603B6 publication Critical patent/SK286603B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C07C315/04—Preparation of sulfones; Preparation of sulfoxides by reactions not involving the formation of sulfone or sulfoxide groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C315/00—Preparation of sulfones; Preparation of sulfoxides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SK546-2002A 1999-10-26 2000-10-11 N-(4,5-bis-Metánsulfonyl-2- metylbenzoyl)guanidínhydrochloridhydrát a spôsob jeho prípravy SK286603B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19951418A DE19951418A1 (de) 1999-10-26 1999-10-26 Verfahren zur Herstellung von N-(4,5-Bismethansulfonyl-2-methyl-benzoyl) -guanidin, Hydrochlorid
PCT/EP2000/009977 WO2001030750A1 (fr) 1999-10-26 2000-10-11 Procede de fabrication de chlorhydrate de n-(4,5-bismethanesulfonyl-2-methyl-benzoyl)-guanidine

Publications (2)

Publication Number Publication Date
SK5462002A3 SK5462002A3 (en) 2002-10-08
SK286603B6 true SK286603B6 (sk) 2009-02-05

Family

ID=7926842

Family Applications (1)

Application Number Title Priority Date Filing Date
SK546-2002A SK286603B6 (sk) 1999-10-26 2000-10-11 N-(4,5-bis-Metánsulfonyl-2- metylbenzoyl)guanidínhydrochloridhydrát a spôsob jeho prípravy

Country Status (26)

Country Link
US (1) US6673968B1 (fr)
EP (1) EP1224166B1 (fr)
JP (1) JP4969750B2 (fr)
KR (1) KR100699571B1 (fr)
CN (1) CN1202078C (fr)
AT (1) ATE250026T1 (fr)
AU (1) AU782471B2 (fr)
BR (1) BR0015022A (fr)
CA (1) CA2388915C (fr)
CZ (1) CZ299201B6 (fr)
DE (2) DE19951418A1 (fr)
DK (1) DK1224166T3 (fr)
ES (1) ES2204712T3 (fr)
HK (1) HK1051358A1 (fr)
HU (1) HU228634B1 (fr)
MX (1) MXPA02004144A (fr)
MY (1) MY122651A (fr)
NO (1) NO328250B1 (fr)
PL (1) PL199010B1 (fr)
PT (1) PT1224166E (fr)
RU (1) RU2276134C2 (fr)
SI (1) SI1224166T1 (fr)
SK (1) SK286603B6 (fr)
UA (1) UA73329C2 (fr)
WO (1) WO2001030750A1 (fr)
ZA (1) ZA200204119B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10023405A1 (de) * 2000-05-12 2001-11-15 Merck Patent Gmbh Verfahren zur Herstellung von Sulfonyl-benzoylguanidinum-Salzen
MXPA05011840A (es) * 2003-05-06 2006-01-26 Merck Patent Gmbh Procedimiento para cristalizar sales de guanidinio.
EP2671576B1 (fr) 2008-05-09 2020-04-08 Merck Patent GmbH Composition pharmaceutique pour le traitement de maladies associées à un dysfonctionnement des cellules beta et de résistance à l'insuline
JOP20200296A1 (ar) * 2013-06-10 2017-06-16 Amgen Inc عمليات صنع وأشكال بلورية من mdm2 مثبط
JP6562221B2 (ja) * 2014-06-23 2019-08-21 日産化学株式会社 スルホニル結合を有するシラン化合物の製造方法
MX2018009558A (es) * 2016-02-08 2018-09-06 Merck Patent Gmbh Modificaciones cristalinas de clorhidrato de n-(4,5-bismetansulfon il-2-metilbenzoil)guanidina y sales de n-(4,5-bismetansulfonil-2-m etilbenzoil)guanidina.
EP3960165A1 (fr) * 2020-08-25 2022-03-02 Fondation EspeRare Inhibiteurs de nhe-1 pour le traitement des infections à coronavirus

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59216865A (ja) * 1983-05-26 1984-12-06 Mitsui Toatsu Chem Inc システイン塩酸塩水和物の乾燥方法
DE3929582A1 (de) * 1989-09-06 1991-03-07 Hoechst Ag Benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament sowie sie enthaltendes medikament
DE59305042D1 (de) * 1992-09-22 1997-02-20 Hoechst Ag Benzoylguanidine, Verfahren zu ihrer Herstellung, sowie ihre Verwendung als Antiarrhythmika
EP0604852A1 (fr) * 1992-12-28 1994-07-06 Hoechst Aktiengesellschaft 5-Sulfamoylbenzoylguanidines 2,4,N-substituées, comme agents antiarhythmiques, inhibiteurs de la prolifération des cellules, et inhibiteurs de l'écharge sodium-hydrogène
JPH07206857A (ja) * 1993-12-28 1995-08-08 Synthelabo Sa アルフゾシン塩酸塩の二水和物
JP3755908B2 (ja) * 1994-08-17 2006-03-15 塩野義製薬株式会社 セファロスポリン化合物の晶析法
ATE185557T1 (de) * 1995-01-30 1999-10-15 Hoechst Ag Basisch-substituierte benzoylguanidine, verfahren zu ihrer herstellung, ihre verwendung als medikament oder diagnostikum sowie sie enthaltendes medikament
DE19502895A1 (de) * 1995-01-31 1996-08-01 Merck Patent Gmbh 4-Mercapto-benzoylguanidin-Derivate
DE19529612A1 (de) * 1995-08-11 1997-02-13 Merck Patent Gmbh Sulfonyl- oder Sulfinyl-benzoylguanidin-Derivate

Also Published As

Publication number Publication date
ZA200204119B (en) 2003-10-29
JP4969750B2 (ja) 2012-07-04
SI1224166T1 (en) 2004-04-30
PL199010B1 (pl) 2008-08-29
HK1051358A1 (en) 2003-08-01
NO20021950D0 (no) 2002-04-25
SK5462002A3 (en) 2002-10-08
UA73329C2 (uk) 2005-07-15
WO2001030750A1 (fr) 2001-05-03
AU1136101A (en) 2001-05-08
PT1224166E (pt) 2004-02-27
DK1224166T3 (da) 2004-01-05
ES2204712T3 (es) 2004-05-01
RU2276134C2 (ru) 2006-05-10
CA2388915C (fr) 2009-12-15
KR100699571B1 (ko) 2007-03-23
AU782471B2 (en) 2005-08-04
MXPA02004144A (es) 2006-01-12
PL355149A1 (en) 2004-04-05
CA2388915A1 (fr) 2001-05-03
CZ299201B6 (cs) 2008-05-14
DE50003759D1 (de) 2003-10-23
BR0015022A (pt) 2002-06-18
MY122651A (en) 2006-04-29
DE19951418A1 (de) 2001-05-03
NO328250B1 (no) 2010-01-18
HU228634B1 (en) 2013-04-29
HUP0203132A3 (en) 2004-12-28
HUP0203132A2 (hu) 2003-01-28
CN1202078C (zh) 2005-05-18
CZ20021354A3 (cs) 2002-09-11
NO20021950L (no) 2002-04-25
US6673968B1 (en) 2004-01-06
JP2003512451A (ja) 2003-04-02
EP1224166A1 (fr) 2002-07-24
ATE250026T1 (de) 2003-10-15
KR20020044572A (ko) 2002-06-15
EP1224166B1 (fr) 2003-09-17
CN1382120A (zh) 2002-11-27

Similar Documents

Publication Publication Date Title
JP2978687B2 (ja) ベンゾイルグアニジンおよびそれを含有する医薬
JP2778450B2 (ja) 置換されたベンゼンスルホニル尿素またはチオ尿素およびそれらの生理学的に許容し得る塩、それらの製法ならびにそれらを含有する医薬
KR100376194B1 (ko) 퍼플로우로알킬치환된벤조일구아니딘,이의제조방법및이를함유하는약제학적조성물
SK281766B6 (sk) Substituované sulfónimidamidy, spôsob ich prípravy, ich použitie ako liečiva alebo diagnostika, ako i liečivo, ktoré ich obsahuje
AU703633B2 (en) Ortho-substituted benzoic acid derivatives
SK286603B6 (sk) N-(4,5-bis-Metánsulfonyl-2- metylbenzoyl)guanidínhydrochloridhydrát a spôsob jeho prípravy
HU226134B1 (en) Sulfonyl- and sulfinyl-benzoyl-guanidine derivatives and pharmaceutical compositions thereof
RU2142940C1 (ru) Производные алкилбензоилгуанидинов, способ их получения и фармацевтическая композиция на их основе
US5807896A (en) Arylbenzoylguanidines
PT743301E (pt) Benzoilguanidinas contendo fluor
HU221851B1 (hu) Fluor-alkil-csoporttal szubsztituált benzoil-guanidin-származékok, eljárás előállításukra, gyógyszerként történő alkalmazásuk, és ezeket tartalmazó gyógyszerkészítmények
SK15812002A3 (sk) Spôsob prípravy sulfonylbenzoylguanidínovej soli

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20181011